DOCSLIB.ORG

Studies on the Bactericidal Ac.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Studies on the Bactericidal Ac.Pdf STUDIES ON THE BACTERICIDAL ACTIVITIES OF THE 4-QUINOLONES Thesis submitted by Bernadette Maria Anne Howard for the degree of Doctor of Philosophy in the University of London. The Microbiology Section, June 1991 Department of Pharmaceutics, The School of Pharmacy, University of London. ProQuest Number: U049390 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest U049390 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 1 ABSTRACT The 4-quinolones act primarily on the A subunit of DNA gyrase coded by the gyrA gene. The nalA mutation in gyrA was found to abolish mechanism B which is the first evidence that mechanism B may reside within gyrase. The coumarins novobiocin and coumermycin inhibit the B subunit of DNA gyrase. The sensitivities of the Escherichia coli KL16 nalR mutants to both coumarins were investigated. New novobiocin-resistant (nov*) and coumermycin-resistant (couR) mutants of E.coli KL16 and Staphylococci warneri were isolated and their sensitivities to ciprofloxacin, novobiocin and coumermycin determined. Both species showed incomplete cross-resistance. Other workers have found that the 4-quinolone antibacterials do not seem to interact with the coumarin antibacterials when minimum inhibitory concentration tests were used to judge interactions. However, when bactericidal interactions between the 4- quinolones and novobiocin or coumermycin were studied in this thesis with E.coli KL16 and Staphylococci significant antagonism of the 4-quinolones by the coumarins was found in all combinations tested. These results agreed with in vivo findings, which hence disagreed with the in vitro results of other workers. SOS DNA repair did not repair damage caused by nalidixic acid, while recombination repair did repair damage caused by the drug. Ciprofloxacin- ofloxacin- and norfloxacin-induced damage, however, showed some differences as regards these DNA repair systems. Nalidixic acid possesses only one mechanism of bactericidal activity, termed A, ciprofloxacin and ofloxacin possess mechanisms A, B and C, while norfloxacin possesses mechanisms A and C. Mechanism B, which does not require protein synthesis or RNA synthesis nor bacteria capable of dividing, was found to operate when drug concentrations reached the co-operative binding concentrations with supercoiled DNA. The effect of the 4-quinolones and coumarin antibacterials on DNA supercoiling was investigated by alkaline or in situ lysis. In-situ lysis was found to be more appropiate than alkaline lysis for such investigations. 4-quinolones are known to exhibit post antibiotic effects (PAE’s). E.coli KL16, Staph, aureus, Klebsiella pneumoniae and Streptococcus pyogenes were investigated for PAE’s with ciprofloxacin, ofloxacin and a new cephalosporin, cefdinir. PAE’s were found with all three drugs in Staph, aureus and Strep, pyogenes. However in E.coli PAE’s were only found with ciprofloxacin or ofloxacin and were generally absent with Klebsiella pneumoniae. 3 ACKNOWLEDGEMENTS I would like to express my deepest thanks and appreciation to Professor J.T. Smith for his supervision, encouragement and support over these last 5 years. I would also like to acknowledge my gratitude and thanks to: Mrs. K. Wood and the technical staff of the Microbiology Section for their expertise and assistance; Dr Phillipe Mazodier and colleagues at Institut Pasteur, Paris for their friendship and kindness; Dr. Clement Lewin as a colleague and friend for his much appreciated support and advice; colleagues past and present for their enthusiasm and support; to the Blatchley family and Turner family who cared and supported me through my illness and all my friends and family for their prayers which have been answered; Miss Jayne Pascoe for her much appreciated friendship and encouragement; and finally to my parents and brother to whom this book is dedicated for their encouragement and support throughout. This thesis was funded by the S.E.R.C. "..When I applied my mind to know the wisdom and to observe man’s labour on earth-his eyes not seeing sleep day or night- then I saw all that God has done. No-one can comprehend what goes on under the sun. Despite all his efforts to search it out, man cannot discover its meaning. Even if a wise man claims he knows, he cannot really comprehend it." Ecclesiastes 8, vl6-17 4 INDEX TO CONTENTS PAGE NUMBER Abstract 1 Acknowledgements 3 Index to contents 4 Index to figures 8 Index to tables 17 Introduction 20 A The Bacterial Chromosome 20 B DNA topoisomerases 21 B.l Topology and energetics of supercoiling 21 B.2 Nomenclature of DNA topoisomerases 23 B.2.1 Type I topoisomerases 23 B.2.1.1 Prokaryotic Type I topoisomerases 23 B.2.1.2 Eukaryotic Type I topoisomerases 24 B.2.2 Type 13 topoisomerases 25 B.2.3 DNA gyrase 25 B.2.3.1 Discovery of DNA gyrase 25 B.2.3.2 Structure of DNA gyrase 26 B.2.3.3. Extraction of DNA gyrase 26 B.2.3.4 Supercoiling of DNA by gyrase 27 B.2.4 Other Type II topoisomerases 28 B.2.4.1 Prokaryotic topoisomerase II’ 28 B.2.4.2 Topoisomerase IV 29 B.2.4.3 T4 DNA topisomerase 29 B.2.4.4 Reverse gyrase 29 B.2.4.5 Eukaryotic type II topoisomerases 30 B.3 Comparison of eukaryotic topoisomerase II with 30 E.coli DNA gyrase B.4 Topoisomerases in mitochondria and chloroplasts 31 and viruses C Physiological role of Topoisomerases 31 C.l Topoisomerases and the level of supercoiling in vivo 31 C.2 Topoisomerases and DNA replication 32 5 INDEX TO CONTENTS (contd.) PAGE NUMBER Introduction (contd.) C.3 Supercoiling effects of topoisomerases on 34 transcription and gene expression D Inhibitors of DNA topoisomerases 40 D.l The coumarin antibacterials 40 D.2 The 4-quinolones 42 D.2.1 Selectivity of the 4-quinolones 44 D.2.2 Clinical use of the 4-quinolones 44 D.2.2.1 In vitro inhibitory antibacterial activity of the 45 4-quinolones D.2.3 Mechanisms of killing of bacteria by 4-quinolones 46 D.2.3.1 Kinetics and Characteristics of killing 47 D.2.3.2 Antagonism of the bactericidal effects of the 47 4-quinolones D.2.3.3 Differences in killing activity among 4-quinolones 48 D.2.3.4 Quinolone-DNA interactions 49 D.2.3.5 Inhibition of DNA synthesis 51 D.2.3.6 DNA damage 51 D.2.3.7 The SOS repair system 52 D.2.3.7 a The recA protein 52 D.2.3.7 b The lexA protein 53 D.2.3.7 c Inducible repair involving recombination functions 53 D.2.3.8 Post antibiotic effect 55 D.2.4 Quinolones and other antibacterials 56 D.2.5 Quinolones and resistance 57 D.2.5.1 Chromosomal mutations in DNA gyrase 58 D.2.5.2 Mutations affecting permeability 59 D.2.5.3 Frequency of resistance to the 4-quinolones 62 INDEX TO CONTENTS (contd.) PAGE NUMBER Abbreviations 64 Materials 67 A Liquid media 67 B Solid media 67 Antimicrobial Agents 69 Bacterial Strains 70 Experimental Methods 75 1. Agarose gel electrophoresis 75 - Chemical reagents and solutions used for alkaline 75 lysis of plasmids for gel electrophoresis - Chemical reagents and solutions for in situ lysis 78 for gel electrophoresis - Method A: Investigation of plasmids in bacteria 79 previously treated with 4-quinolones in intact cells - Protocol for extraction of plasmid DNA by alkaline 80 lysis - Preparation of Agarose gels 81 - Loading the gel 81 - Running the gel 82 - Visualisation of gel 82 - Method B: In situ lysis of large plasmids 83 - Preparation of agarose gels 83 2. Mininmum inhibitory concentrations 84 - Preparation of plates 84 - Preparation of cultures 84 3. Fractional Inhibitory Concentration Tests 85 4. Bactericidal tests 85 5. Measurement of the rate of kill by 86 4-quinolones 6. Isolation of resistant mutants 87 7. Measuring the UV survival of UV sensitive 88 bacteria 8. Post Antiobiotic Effect 88 INDEX TO CONTENTS (contd.) PAGE NUMBER RESULTS Chapter One The action of the 4-quinolones on DNA gyrase mutants. 90 Chapter Two Sensitivity and mutational resistance to the 109 coumarin antibacterials. Chapter Three Interactions between the bactericidal effects of 131 4-quinolones and other gyrase inhibitors. Chapter Four The effect of 4-quinolones on recombination and 173 SOS repair. Chapter Five Mechanisms of kill of the 4-quinolones. 190 Chapter Six Development of an in vitro assay to determine the 207 effect of gyrase inhibitors on plasmid supercoiling. Chapter Seven Post antibiotic effects of ciprofloxacin, ofloxacin 228 and a new cephalosporin, cefdinir. DISUSSION 262 1. -The effect of DNA gyrase mutations on the 262 bactericidal mechanisms of the 4-quinolones. 2. -Sensitivity and mutational resistance to the 264 coumarin antibacterials. 3. -The effects of combinations of 4-quinolones and 266 coumarin antibacterials. 4. -The role of DNA repair processes in 4-quinolone 268 lethality. 5. -The characteristics of mechanism B and C and 269 the possible involvement of co-operative binding. 6. -Changes in supercoiling in intact bacterial cells. 271 7. -The potential role of 4-quinolones and cefdinir 273 based on the post antibiotic effects. REFERENCES 276 8 INDEX TO FIGURES FIGURE TITLE PAGE NUMBER 1 Chemical structure of the coumarin antibacterials.
Load more

Recommended publications
  • 1057-1064, 1984 the Effect of Pipemidic Acid on The
    Microbiol. Immunol. Vol. 28 (9), 1057-1064, 1984 The Effect of Pipemidic Acid on the Growth of a Stable L-Form of •ôNH•ôStaphylococcus aureus•ôNS•ô Kunihiko YABU,*,1 Hiromi ToMizu,1 and Yayoi KANDA2 1 Department of Biology, Hokuriku University School of Pharmacy, Kanazawa-machi, Kanazawa, Ishikawa ,920-11, and 2Department of Microbiology, Teikyo University School of Medicine, Kaga 2-chome, Ilabashi-ku, Tokyo 173 (Accepted for publication, June 12, 1984) Bacterial L-forms usually display spherical forms in an osmotically protective medium and seem to lack the typical binary fission process of cellular division ob servedin most bacteria (7). Although various modes of replication, such as budding binary fission, and release of elementary bodies from large bodies have been observed by light and electron microscopy (2, 5, 16), little is known about the processes involved in replication of L-forms. In the course of an experiment designed to test the effect of DNA synthesis inhibitors on the growth of a stable L-form of •ôNH•ôStaphylococcus•ôNS•ôaureus which grows in liquid medium, it was found that pipemidic acid, a synthetic antibacterial agent structurally related to nalidixic acid (13), induced a marked morphological altera tionat growth inhibitory concentrations. This study was initiated in an attempt to clarify the mechanism of replication of stable L-forms by analyzing the mor phologicalalteration caused by pipemidic acid. The stable L-form used was isolated as follows. S. •ôNH•ôaureus•ôNS•ôFDA 209P was grown in 10ml of Brain Heart Infusion broth (Difco) at 37C. The culture grown at 5•~105 colony-forming units (CFU) per ml was washed with saline by filtration and suspended in saline containing 100ƒÊg of N-methyl-N'-nitro-N-nitrosoguanidine per nil.
    [Show full text]
  • Resistance Pattern of Coagulase Positive Staphylococcus Aureus Clinical Isolates from Asir Region, Kingdom of Saudi Arabia
    Journal of Microbiology and Antimicrobials Vol. 3(4), pp. 102-108, April 2011 Available online http://www.academicjournals.org/JMA ISSN 2141-2308 ©2011 Academic Journals Full Length Research Paper Resistance pattern of coagulase positive Staphylococcus aureus clinical isolates from Asir region, Kingdom of Saudi Arabia Mohamed E. Hamid Department of Microbiology, College of Medicine, King Khalid University, P. O. Box 641, Abha, Kingdom of Saudi Arabia. E-mail: [email protected]. Accepted 6 April, 2011 The objectives of this study were to determine the prevalence of methicillin resistant coagulase positive Staphlococcus aureus (MRSA) infections in two major hospitals in Asir region, Kingdom of Saudi Arabia and to compare it with the community-acquired infections. Two hundreds and ten coagulase positive S. aureus recovered from 9831 specimens from various infections at Asir Central Hospital and Abha General Hospital, KSA (Kingdom of Saudi Arabia), were tested against 44 commonly used antibacterial agents. One hundred of the isolates were from hospital-acquired infections, 100 from community-acquired infections and 10 isolates were collected from the hospital environment. All isolates were found resistant to aztreonam, colistin, mecillinam, metronidazole, polymyxin B and nalidixic acid but were sensitive to vancomycin, nitrofurantoin and novobiocin. Various levels of resistant were recorded for the remaining antibiotics. High resistance to antimicrobial agents was detected among hospital acquired infections compared to community acquired infections (p<0.01). The resistance rates of S. aureus to antimicrobial agents among hospital acquired infections isolates were significantly higher (p<0.05) than community acquired infections. This implies that hospital environment is a strong risk factor for the prevalence of MRSA in the hospitalized patients, visitors, and hospital staff with potential risk of spreading to the community.
    [Show full text]
  • Microbiological Air Quality and Drug Resistance in Airborne Bacteria Isolated from a Waste Sorting Plant Located in Poland—A Case Study
    microorganisms Article Microbiological Air Quality and Drug Resistance in Airborne Bacteria Isolated from a Waste Sorting Plant Located in Poland—A Case Study Ewa Br ˛agoszewska 1,* , Izabela Biedro ´n 2 and Wojciech Hryb 1 1 Faculty of Power and Environmental Engineering, Department of Technologies and Installations for Waste Management, Silesian University of Technology, 18 Konarskiego St., 44-100 Gliwice, Poland; [email protected] 2 Institute for Ecology of Industrial Areas, Environmental Microbiology Unit, 6 Kossutha St., 40-844 Katowice, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-322-372-762 Received: 13 December 2019; Accepted: 29 January 2020; Published: 31 January 2020 Abstract: International interests in biological air pollutants have increased rapidly to broaden the pool of knowledge on their identification and health impacts (e.g., infectious, respiratory diseases and allergies). Antibiotic resistance and its wider implications present us with a growing healthcare crisis, and an increased understanding of antibiotic-resistant bacteria populations should enable better interpretation of bioaerosol exposure found in the air. Waste sorting plant (WSP) activities are a source of occupational bacterial exposures that are associated with many health disorders. The objectives of this study were (a) to assess bacterial air quality (BAQ) in two cabins of a WSP: preliminary manual sorting cabin (PSP) and purification manual sorting cabin (quality control) (QCSP), (b) determine the particle size distribution (PSD) of bacterial aerosol (BA) in PSP, QCSP, and in the outdoor air (OUT), and (c) determine the antibiotic resistance of isolated strains of bacteria. Bacterial strains were identified on a Biolog GEN III (Biolog, Hayward, CA, USA), and disc diffusion method for antimicrobial susceptibility testing was carried out according to the Kirby–Bauer Disk Diffusion Susceptibility Test Protocol.
    [Show full text]
  • Antibiotic Sensitivity of Bacterial Pathogens Isolated from Bovine Mastitis Milk
    Content of Research Report A. Project title: Antibiotic Sensitivity of Bacterial Pathogens Isolated From Bovine Mastitis Milk B. Abstract: Antibiotic sensitivity of bacteria isolated from bovine milk samples was investigated. The 18 antibiotics that were evaluated (e.g., penicillin, novobiocin, gentamicin) are commonly used to treat various diseases in cattle, including mastitis, an inflammation of the udder of dairy cows. A common concern in using antibiotics is the increase in drug resistance with time. This project studies if antibiotic resistance is a threat to consumers of raw milk products and if these antibiotics are still effective against mastitis pathogens. The study included isolating and culturing bacteria from quarter milk samples (n=205) collected from mastitic dairy cows from farms in Chino and Ontario, CA. The isolated bacteria were tested for sensitivity to antibiotics using the Kirby Bauer disk diffusion method. The prevalence (%) of resistance to the individual antibiotics was reported. Resistance to penicillin was 45% which may support previous data on penicillin-resistant bacteria, especially Staphylococcus and Streptococcus. Resistance rates (%) for oxytetracycline (26.8%) and tetracycline (22.9%) were low compared to previous studies but a trend was seen in our results that may support concerns of emerging resistance to tetracyclines in both gram- positive and gram-negative bacteria. Similarly, 31.9% of bacterial isolates showed resistance to erythromycin which is at least 30% less than in reported literature concerning emerging resistance to macrolides. More numbers (%) that should be noted are cefazolin (26.3%), ampicillin (29.7%), novobiocin (33.0%), polymyxin B (31.5%), and resistance ranging from 9­ 18% for the other antibiotics.
    [Show full text]
  • WHO Report on Surveillance of Antibiotic Consumption: 2016-2018 Early Implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some Rights Reserved
    WHO Report on Surveillance of Antibiotic Consumption 2016-2018 Early implementation WHO Report on Surveillance of Antibiotic Consumption 2016 - 2018 Early implementation WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution- NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons. org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non- commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • On the Extraction of Antibiotics from Shrimps Prior to Chromatographic Analysis
    separations Review On the Extraction of Antibiotics from Shrimps Prior to Chromatographic Analysis Victoria Samanidou *, Dimitrios Bitas, Stamatia Charitonos and Ioannis Papadoyannis Laboratory of Analytical Chemistry, University of Thessaloniki, GR 54124 Thessaloniki, Greece; [email protected] (D.B.); [email protected] (S.C.); [email protected] (I.P.) * Correspondence: [email protected]; Tel.: +30-2310-997698; Fax: +30-2310-997719 Academic Editor: Frank L. Dorman Received: 2 February 2016; Accepted: 26 February 2016; Published: 4 March 2016 Abstract: The widespread use of antibiotics in veterinary practice and aquaculture has led to the increase of antimicrobial resistance in food-borne pathogens that may be transferred to humans. Global concern is reflected in the regulations from different agencies that have set maximum permitted residue limits on antibiotics in different food matrices of animal origin. Sensitive and selective methods are required to monitor residue levels in aquaculture species for routine regulatory analysis. Since sample preparation is the most important step, several extraction methods have been developed. In this review, we aim to summarize the trends in extraction of several antibiotics classes from shrimps and give a comparison of performance characteristics in the different approaches. Keywords: sample preparation; extraction; aquaculture; shrimps; chromatography; antibiotics 1. Introduction According to FAO (CWP Handbook of Fishery Statistical Standards, Section J: AQUACULTURE), “aquaculture is the farming of aquatic organisms: fish, mollusks, crustaceans, aquatic plants, crocodiles, alligators, turtles, and amphibians. Farming implies some form of intervention in the rearing process to enhance production, such as regular stocking, feeding, protection from predators, etc.”[1]. Since 1960, aquaculture practice and production has increased as a result of the improved conditions in the aquaculture facilities.
    [Show full text]
  • The Sensitivity in Vitro of the Providence And
    J Clin Pathol: first published as 10.1136/jcp.11.3.270 on 1 May 1958. Downloaded from J. clin. Pat/i. (1958), 11, 270. THE SENSITIVITY IN VITRO OF THE PROVIDENCE GROUP OF ENTERIC BACTERIA TO 14 ANTIBIOTICS AND NITROFURANTOIN BY J. E. MIDDLETON From the Louis Jenner Laboratory, St. Thomas's Hospital and Medical School, London (RECEIVED FOR PUBLICATION JANUARY 8, 1958) During the course of an investigation into the oxytetracycline (100 Pg.), chloramphenicol (100 p-g.), antibiotic sensitivity of strains of the Proteus polymyxin (500 u.), and nitrofurantoin 10,000 pg.). per paper disc or group of bacteria isolated from infections of the (The concentration of each drug test tablet is given in brackets.) A zone of inhi- urinary tract (Middleton, 1957) a few strains of bition of growth 10 mm. or more in diameter were examined. This the Providence group also was considered to indicate sensitivity to the anti- group of the Enterobacteriaceae called type 29911 biotics, the discs or test tablets being 5 mm. in by Stuart, Wheeler, Rustigian, and Zimmerman diameter. Any inhibition of growth round the nitro- (1943), and named Providence by Kauffmann furantoin test tablet was taken to indicate that the (1951), has close affinities in many characteristics organism was sensitive to the drug. with the Proteus group (Singer and Bar-Chay, A few strains were also tested by the serial dilution copyright. 1954), and a similarity between strains of the two technique against streptomycin, tetracycline, and ml.) of a groups was found here in their common resistance chloramphenicol. A standard drop (0.02 dilution of an overnight broth culture was to many antibiotics in vitro.
    [Show full text]
  • Surveillance of Antimicrobial Consumption in Europe 2013-2014 SURVEILLANCE REPORT
    SURVEILLANCE REPORT SURVEILLANCE REPORT Surveillance of antimicrobial consumption in Europe in Europe consumption of antimicrobial Surveillance Surveillance of antimicrobial consumption in Europe 2013-2014 2012 www.ecdc.europa.eu ECDC SURVEILLANCE REPORT Surveillance of antimicrobial consumption in Europe 2013–2014 This report of the European Centre for Disease Prevention and Control (ECDC) was coordinated by Klaus Weist. Contributing authors Klaus Weist, Arno Muller, Ana Hoxha, Vera Vlahović-Palčevski, Christelle Elias, Dominique Monnet and Ole Heuer. Data analysis: Klaus Weist, Arno Muller and Ana Hoxha. Acknowledgements The authors would like to thank the ESAC-Net Disease Network Coordination Committee members (Marcel Bruch, Philippe Cavalié, Herman Goossens, Jenny Hellman, Susan Hopkins, Stephanie Natsch, Anna Olczak-Pienkowska, Ajay Oza, Arjana Tambić Andrasevic, Peter Zarb) and observers (Jane Robertson, Arno Muller, Mike Sharland, Theo Verheij) for providing valuable comments and scientific advice during the production of the report. All ESAC-Net participants and National Coordinators are acknowledged for providing data and valuable comments on this report. The authors also acknowledge Gaetan Guyodo, Catalin Albu and Anna Renau-Rosell for managing the data and providing technical support to the participating countries. Suggested citation: European Centre for Disease Prevention and Control. Surveillance of antimicrobial consumption in Europe, 2013‒2014. Stockholm: ECDC; 2018. Stockholm, May 2018 ISBN 978-92-9498-187-5 ISSN 2315-0955
    [Show full text]
  • Antibiotic Sensitivity
    Microbiology Laboratory (BIOL 3702L) Page 1 of 7 DIFFERENTIATION OF COCCI BY ANTIBIOTIC SENSITIVITY PriNciple and Purpose Antibiotics are substances that inhibit cellular growth and possibly reduce viability. In microbiology, antibiotics function by exploiting “chinks” in a microbe’s metabolic processes. However, closely-related species within and across different genera can respond to the effects of antibiotics in different ways. Mainly, some species are sensitive to a given antibiotic, whereas others are not. These differences can be used in the laboratory to help distinguish between closely-related or morphologically-similar species of bacteria. This exercise takes advantage of how different species of Staphylococcus respond to the antibiotic novobiocin. Similarly, differences among Streptococcus, Enterococcus, Staphylococcus, and Micrococcus will be observed in response to the antibiotic bacitracin and the combination antibiotic, SXT (which includes trimethoprim and sulfamethoxazole). LearNiNg Objectives Upon completion of this exercise, a student should be able to: • Understand how different strains of cocci can be differentiated based upon antibiotic sensitivity; • Properly conduct the antibiotic sensitivity tests; and • Accurately interpret the results of this test. Materials Required The following materials are necessary to successfully conduct this exercise: Organisms - The following organisms should be provided as 24-48 hour-old TSA or TSB cultures: • Enterococcus faecalis (ATCC 19433) [abbreviated as E. faecalis] • Micrococcus luteus (ATCC 4698) [abbreviated at M. luteus] • Staphylococcus aureus (ATCC 25923) [abbreviated at S. aureus] • Staphylococcus epidermidis (ATCC 12228) [abbreviated at S. epidermidis] • Staphylococcus saprophyticus (ATCC 49453) [abbreviated at S. saprophyticus] • Streptococcus pyogenes (ATCC 19615) [abbreviated at S. pyogenes] Materials • Blood agar (BA) plates • Antibiotic disks (Hardy Diagnostics, Santa Maria, CA) o Novobiocin (Cat.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Isolation and Characterization of Norfloxacin-Resistant Mutants Of
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1986, p. 248-253 Vol. 30, No. 2 0066-4804/86/080248-06$02.00/0 Copyright © 1986, American Society for Microbiology Isolation and Characterization of Norfloxacin-Resistant Mutants of Escherichia coli K-12 KEIJI HIRAI,'* HIROSHI AOYAMA,1 SEIGO SUZUE,1 TSUTOMU IRIKURA,1 SHIZUKO IYOBE,2 AND SUSUMU MITSUHASHI3 Central Research Laboratories, Kyorin Pharmaceutical Co. Ltd., Nogi-machi, Shimotsuga-gun, Tochigi,l Department of Microbiology, School ofMedicine, Gunma University, Maebashi, Gunma,2 and Episome Institute, Fujimi, Gunma,3 Japan Received 30 December 1985/Accepted 19 May 1986 We isolated spontaneous mutants from Escherichia coli K-12 with low-level resistance to norfloxacin. These mutants were classified into the following three types on the basis of their properties: (i) NorA appeared to result for mutation in the gyrA locus for the A subunit of DNA gyrase; (ii) NorB showed low-level resistance to quinolones and other antimicrobial agents (e.g., cefoxitin, chloramphenicol, and tetracycline), and the norB gene was considered to map at about 34 min on the E. coli K-12 chromosome; (iii) NorC was less susceptible to norfloxacin and ciprofloxacin but was hypersusceptible to hydrophobic quinolones such as nalidixic acid and rosoxacin, hydrophobic antibiotics, dyes, and detergents. Susceptibility to bacteriophages and the hydropho- bicity of the NorC cell surface also differed from that of the parent strain. The norC gene was located near the lac locus at 8 min on the E. coli K-12 chromosome. Both NorB and NorC mutants had a lower rate of norfloxacin uptake, and it was found that the NorB mutant was altered in OmpF porin and that the NorC mutant was altered in both OmpF porin and apparently in the lipopolysaccharide structure of the outer membrane.
    [Show full text]
  • Adjunctive Use of Rifampin for the Treatment of Staphylococcus Aureus Infections: a Systematic Review of the Literature
    REVIEW ARTICLE Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections A Systematic Review of the Literature Joshua Perlroth, MD; Melissa Kuo, MD; Jennifer Tan, MHS; Arnold S. Bayer, MD; Loren G. Miller, MD, MPH Background: Staphylococcus aureus causes severe life- efit of adjunctive rifampin use, particularly in osteomy- threatening infections and has become increasingly com- elitis and infected foreign body infection models; however, mon, particularly methicillin-resistant strains. Rif- many studies failed to show a benefit of adjunctive therapy. ampin is often used as adjunctive therapy to treat S aureus Few human studies have addressed the role of adjunc- infections, but there have been no systematic investiga- tive rifampin therapy. Adjunctive therapy seems most tions examining the usefulness of such an approach. promising for the treatment of osteomyelitis and pros- thetic device–related infections, although studies were Methods: A systematic review of the literature to iden- typically underpowered and benefits were not always seen. tify in vitro, animal, and human investigations that com- pared single antibiotics alone and in combination with Conclusions: In vitro results of interactions between rif- rifampin therapy against S aureus. ampin and other antibiotics are method dependent and often do not correlate with in vivo findings. Adjunctive Results: The methods of in vitro studies varied substan- rifampin use seems promising in the treatment of clini- tially among investigations. The effect of rifampin therapy cal hardware infections or osteomyelitis, but more de- was often inconsistent, it did not necessarily correlate with finitive data are lacking. Given the increasing incidence in vivo investigations, and findings seemed heavily de- of S aureus infections, further adequately powered in- pendent on the method used.
    [Show full text]